Pharmacokinetics and Immunogenicity of the First Doses of PEG-Asparaginase -An ALLTogether Pilot Study
NCT04843150
·
clinicaltrials.gov ↗
COMPLETED
Status
320
Enrollment
OTHER
Sponsor class
Conditions
Acute Lymphoblastic Leukemia
Sponsor
Aarhus University Hospital